SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
NEW YORK, Nov. 15, 2017 -- As NFL football season delivers high-impact hits week after week, Leonard Marshall isn’t letting the NFL off the hook with his latest challenge.
|
|||||
“We need to get rid of the old guard [in the NFL],” he told Newsweek in it's special edition covering cannabis.
Current NFL players who don’t want to risk testing positive on drug tests that don’t differentiate between THC and CBD are waiting for the NFL to approve CBD for its anti-inflammatory and neuroprotective properties.
“We need something like a panel talking to players and ex-players about CBD products that might replace the drugs players get now,” he continues.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2662c5a0-cda0-47b2-9c1a-2ad2b9cda01c
Marshall has often said some of his motivation is to “save lives,” of former players like himself who are subjected to repeated head trauma. As Newsweek reports, head trauma is responsible for ruining the lives of many former NFL players blamed on the suicides of numerous NFL players including Aaron Hernandez’s last spring and famously, Junior Seau.
Marshall, who recently made headlines as the first CBD advocate to receive a NFL Hall of Fame nomination after he announced he is donating his brain to CTE research, played for the New York Giants and the New Jersey Jets during his storied career which earned him two Super Bowl championships.
Marshall first started using CBD in 2013 after his CTE diagnosis, “I started changing—in the role of a husband and provider—due to the aftermath of head trauma,” he stated. Marshall’s recent CTE video diary has received almost 30,000 views to date.
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products in 27 countries globally including United States, Japan, Puerto Rico, Brazil and throughout Europe. More information available at Elixinol.com.
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]
